Protocol compliance in a multicentric phase III trial investigating scheduled adaptive radiotherapy and dose painting in head and neck cancer.
de Leeuw ALMP, Giralt J, Tao Y, Benavente S, Nguyen TF, Hoebers FJP, Hoeben A, Terhaard CHJ, Lee LW, Friesland S, Steenbakkers RJHM, Tans L, van Kranen SR, van de Kamer JB, Bartelink H, Rasch CRN, Sonke JJ, Hamming-Vrieze O.
de Leeuw ALMP, et al.
Radiother Oncol. 2024 Nov 8:110612. doi: 10.1016/j.radonc.2024.110612. Online ahead of print.
Radiother Oncol. 2024.
PMID: 39522824